For example, SRD5A3 is overexpressed in hepatocellular carcinoma, breast carcinoma, endometrial carcinoma, and prostate carcinoma, and patients with SRD5A3 high expression suggest a poor prognosis [19–21]. The gene discussed is SRD5A3; the disease is hepatocellular carcinoma.